keyword
https://read.qxmd.com/read/38759402/a-challenging-diagnosis-and-treatment-of-embryonal-rhabdomyosarcoma-in-the-cervix-of-an-adult-woman-a-surgical-case-report
#1
Hamza Messaoudi, Abdelhamid Benlghazi, Abderrahim Elktaibi, Moad Belouad, Elhassani Moulay Mehdi, Jaouad Kouach
INTRODUCTION AND IMPORTANCE: Embryonal Rhabdomyosarcoma is a rare form of sarcoma mainly seen in children and adolescents. In the specific case of the cervix, embryonal Rhabdomyosarcoma is an extremely rare mesenchymal tumor, accounting for <1 % of all cervical cancers. This highly malignant tumor mainly affects adolescents and young adults. CASE PRESENTATION: We describe the case of a 29-year-old woman with embryonal rhabdomyosarcoma of the cervix, which manifested as an exophytic cervical mass...
May 9, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38757485/clinical-features-and-outcomes-of-young-patients-with-low-grade-non-rhabdomyosarcoma-soft-tissue-sarcomas-treated-with-a-risk-based-strategy-a-report-from-children-s-oncology-group-study-arst0332
#2
JOURNAL ARTICLE
David P Douglass, Cheryl M Coffin, R Lor Randall, Yan Yang, Donald A Barkauskas, Lynn Million, M Beth McCarville, Alberto S Pappo, Aaron R Weiss, Sheri L Spunt
BACKGROUND: In retrospective analyses, the Pediatric Oncology Group [POG) and the Federation National des Centres de Lutte Contre le Cancer (FNCLCC) histologic grade predict outcome in pediatric non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), but prospective data on grading, clinical features, and outcomes of low-grade NRSTS are limited. METHODS: We analyzed patients less than 30 years of age enrolled on Children's Oncology Group (COG) study ARST0332 (NCT00346164) with POG grade 1 or 2 NRSTS...
May 16, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38722224/genomic-profiling-of-pleomorphic-rhabdomyosarcoma-reveals-a-genomic-signature-distinct-from-that-of-embryonal-rhabdomyosarcoma
#3
JOURNAL ARTICLE
Carla Saoud, Josephine K Dermawan, Aarti E Sharma, William Tap, Leonard H Wexler, Cristina R Antonescu
Pleomorphic rhabdomyosarcoma (PRMS) is a rare and highly aggressive sarcoma, occurring mostly in the deep soft tissues of middle-aged adults and showing a variable degree of skeletal muscle differentiation. The diagnosis is challenging as pathologic features overlap with embryonal rhabdomyosarcoma (ERMS), malignant Triton tumor, and other pleomorphic sarcomas. As recurrent genetic alterations underlying PRMS have not been described to date, ancillary molecular diagnostic testing is not useful in subclassification...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38707732/pleomorphic-rhabdomyosarcoma-of-the-uterine-corpus-in-an-adult-who-underwent-multi-gene-panel-testing
#4
JOURNAL ARTICLE
Tamami Odai, Noriko Oshima, Yusuke Kori, Maki Takao, Kimio Wakana, Naoyuki Miyasaka
BACKGROUND/AIM: Rhabdomyosarcoma (RMS) is the most common malignant soft tissue tumor in children. Adult primary RMS of gynecological origin is a rare condition and uterine RMS is an aggressive malignancy with a poor prognosis. The genetic variants associated with uterine RMS in adults have yet to be fully elucidated, and there is no established therapeutic strategy for rare tumors. CASE REPORT: A 69-year-old Japanese woman was referred to our hospital with abdominal bloating...
2024: Cancer Diagn Progn
https://read.qxmd.com/read/38679641/preliminary-study-on-the-optical-diagnosis-of-orbital-rhabdomyosarcoma-by-raman-spectroscopy
#5
JOURNAL ARTICLE
Ling Jin, Nengli Dai, Xiaobo Yang
To investigate the Raman spectral features of orbital rhabdomyosarcoma (ORMS) tissue and normal orbital tissue in vitro, and to explore the feasibility of Raman spectroscopy for the optical diagnosis of ORMS. 23 specimens of ORMS and 27 specimens of normal orbital tissue were obtained from resection surgery and measured in vitro using Raman spectroscopy coupled to a fiber optic probe. The important spectral differences between the tissue categories were exploited for tissue classification with the multivariate statistical techniques of principal component analysis (PCA) and linear discriminant analysis (LDA)...
April 28, 2024: Scientific Reports
https://read.qxmd.com/read/38677984/embryonal-and-alveolar-rhabdomyosarcoma-in-adolescents-young-adults-adults-and-older-adults-a-population-based-cohort-study
#6
JOURNAL ARTICLE
Hiroshi Kobayashi, Koichi Okajima, Liuzhe Zhang, Toshihide Hirai, Yuki Ishibashi, Yusuke Tsuda, Masachika Ikegami, Akira Kawai, Sakae Tanaka
BACKGROUND: The clinical characteristics, outcomes, and prognostic factors of adult embryonal rhabdomyosarcomas (ERMS) and alveolar rhabdomyosarcomas (ARMS), particularly the differences among adolescents/young adults (AYA), adults, and older adults, remain unclear. We assessed the clinicopathological features and survival outcomes of adult patients with ERMS and ARMS in Japan and to compare these features among AYA, adult, and older adult patients. METHODS: We retrospectively analyzed data from the Bone and Soft Tissue Tumor Registry of Japan and enrolled patients aged ≥15 years with ERMS and ARMS...
April 27, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38644703/multimodality-imaging-evaluation-of-nasal-rhabdomyosarcoma-in-adults-a-case-report-and-literature-review
#7
Lujiao Chen, Bo Chen, Shanlu Yu, Zhenhua Zhao, Liyijing Shen
BACKGROUND: Alveolar rhabdomyosarcoma (ARMS) predominantly affects adolescents aged 10-15 years and is distinguished by its high aggressiveness and adverse prognosis compared with other sarcomas. It exhibits a pronounced tendency for lymphatic and hematogenous metastases at early stages. ARMS commonly manifests in the limbs and genitourinary system, with occurrences in the head and neck region being relatively uncommon. The role of CT, MRI, and 18F-FDG positron emission tomography combined with computed tomography (PET/CT) in the diagnostic process of ARMS is yet to be fully established...
April 19, 2024: Current Radiopharmaceuticals
https://read.qxmd.com/read/38637236/mandibular-rhabdomyosarcoma-with-tfcp2-rearrangement-and-osteogenic-differentiation-a-case-misdiagnosed-as-fibrous-dysplasia-or-low-grade-central-osteosarcoma
#8
Fu Chen, Junjia Wang, Yanan Sun, Jiali Zhang
Rhabdomyosarcoma with TFCP2-related fusions (TFCP2-RMS) is a rare entity that commonly affects young adults with a predilection for skeletal involvement. We herein report a 40-year-old female patient with TFCP2-RMS who was misdiagnosed as fibrous dysplasia or low-grade central osteosarcoma of the mandible by referring institutions. Histologically, the tumor showed dominant spindle cells and focal epithelioid cells with marked immature woven bone formation. Immunophenotypically, in addition to the characteristic expression of myogenic markers, ALK, and cytokeratins, tumor cells also unusually expressed osteogenic markers, such as MDM2 and SATB2...
January 11, 2024: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
https://read.qxmd.com/read/38588921/brachytherapy-for-rhabdomyosarcoma-survey-of-international-clinical-practice-and-development-of-guidelines
#9
JOURNAL ARTICLE
Raquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, Tom Boterberg, Alison Cameron, Joerg Fuchs, Florent Guérin, Peter Hoskin, Matthew J Krasin, Petra Kroon, Henriette Magelssen, Claes Mercke, Johannes H M Merks, Frank Paulsen, Pascal Pommier, Monica Ramos, Helen Rees, Tim Rogers, Maximilian Schmid, Guido Seitz, Olga Slater, Naima Smeulders, Jakob Stenman, Sheila Terwisscha, Cyrus Chargari, Henry C Mandeville
BACKGROUND AND PURPOSE: The purpose of this study was to address the lack of published data on the use of brachytherapy in pediatric rhabdomyosarcoma by describing current practice as starting point to develop consensus guidelines. MATERIALS AND METHODS: An international expert panel on the treatment of pediatric rhabdomyosarcoma comprising 24 (pediatric) radiation oncologists, brachytherapists and pediatric surgeons met for a Brachytherapy Workshop hosted by the European paediatric Soft tissue Sarcoma Study Group (EpSSG)...
April 6, 2024: Radiotherapy and Oncology
https://read.qxmd.com/read/38571873/rhabdomyosarcoma-in-adults-de-novo-or-conversion-from-non-seminomas
#10
Moutaz Ghrewati, Anas Mahmoud, Tala Beliani, Mehandar Kumar
Rhabdomyosarcoma (RMS) is a highly sporadic, very aggressive, and fatal soft tissue tumor in adults. Although more common and treatable in the pediatric population, the occurrence of pleomorphic RMS in adults has a low incidence. Hence, it is not easy to treat. Surgery is the primary definitive treatment, along with radiation therapy, while adjuvant chemotherapy has recently gained popularity. We present an infrequent case of RMS in a patient with a recent history of mixed non-seminomatous germ-cell tumor testicular cancer...
March 2024: Curēus
https://read.qxmd.com/read/38562397/embryonal-rhabdomyosarcoma-of-the-prostate-clinico-pathological-highlights-with-review-of-literature
#11
Anshima Singh, Ravi Hari Phulware, Arvind Kumar, Sanjeev Kishore
Rhabdomyosarcoma (RMS) is the third most common extra-cranial sarcoma occurring in childhood, adolescents, and young adults (AYAs); and is rare in adults. Literature about RMS mainly considers RMS in AYAs, either with that in the children or adults, even though histological, molecular, and clinical characteristics of RMS in AYAs are significantly different from either of the two. Herein, we report a case of prostatic embryonal RMS, in a 17-year-old boy, along with the review of literature of prostatic RMS, with emphasis on AYAs...
2024: Journal of the West African College of Surgeons
https://read.qxmd.com/read/38556817/-congenital-spindle-cell-sclerosing-rhabdomyosarcoma-a-clinicopathological-analysis
#12
JOURNAL ARTICLE
J T Xu, L B Fu, X F Yao, C Jia, X X Guan, M Zhang, L J He
Objective: To investigate the clinicopathological features, immunophenotype and molecular genetic characteristics of congenital spindle cell/sclerosing rhabdomyosarcoma. Methods: Sixteen cases (including 10 consultation cases) of congenital spindle cell/sclerosing rhabdomyosarcoma diagnosed at the Beijing Children's Hospital, Capital Medical University, Beijing China, from April 2017 to January 2022 were collected. These cases were evaluated for clinical profiles, histomorphological features, immunophenotype and molecular characteristics...
April 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38520005/primary-alveolar-rhabdomyosarcoma-of-the-brain-a-case-report
#13
JOURNAL ARTICLE
Layal Al Mahmasani, Marwan Najjar, Roula Hourany, Abeer Tabbarah, Sara Sinno, Nathalie Chamseddine, Reine Abou Zeidane, Ghid Amhaz, Bassem Youssef, Hazem I Assi
BACKGROUND: Primary brain rhabdomyosarcoma is a rare primary brain malignancy with few case reports. The vast majority of cases of primary brain rhabdomyosarcoma occur in pediatric patients, and immunohistochemistry can distinguish it from embryonal subtypes; however, few cases of primary brain rhabdomyosarcoma in adults have been reported in the literature. CASE PRESENTATION: We report the case of a 26-year-old White male patient who was found to have primary brain alveolar rhabdomyosarcoma after developing headaches for several months...
March 23, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38501994/spindle-cell-embryonal-rhabdomyosarcoma-of-the-prostate-in-an-adult-patient-a-case-report-and-review-of-the-literature
#14
JOURNAL ARTICLE
Hanwen Luo, Xiangtao Weng, Zibin Zhong, Xiongwei Shan, Wenli Lin, Siyi Li, Chiming Gu
Rhabdomyosarcoma of the prostate is a rare mesenchymal tumor that originates from undifferentiated mesenchymal cells. Spindle cell rhabdomyosarcoma is a variant of embryonal rhabdomyosarcoma. The vast majority of these two pathological types occur in children, with only a few adult cases reported to date, and both are associated with poor clinical outcomes. We herein report a case involving a man in his early 40s with spindle cell embryonal rhabdomyosarcoma of the prostate. His chief complaint was difficult urination...
March 2024: Journal of International Medical Research
https://read.qxmd.com/read/38500901/unraveling-the-clinicopathological-diversity-and-subtypes-of-rhabdomyosarcoma-a-study-from-a-tertiary-care-center
#15
JOURNAL ARTICLE
Harika Mandava, Inuganti Venkata Renuka, Sudhakar Ramamoorthy
Background and objective Rhabdomyosarcoma (RMS) is a rare and malignant mesenchymal tumor characterized by skeletal muscle differentiation. While it is a common soft tissue sarcoma in children, its incidence significantly decreases with advancing age, rendering it exceptionally rare in individuals aged more than 45 years. This study aimed to shed light on the clinicopathological diversity and subtypes of RMS, thereby providing a comprehensive overview for enabling diagnostic precision and therapeutic strategies in treating this infrequently encountered malignancy in adults...
February 2024: Curēus
https://read.qxmd.com/read/38486204/adult-head-and-neck-rhabdomyosarcoma-radiotherapy-based-treatment-outcomes-and-predictors-of-survival
#16
JOURNAL ARTICLE
Dan Zhao, Fang Zhou, Weixin Liu, Zhou Huang, Xiaolong Xu, Baomin Zheng, Changqing Liu, Chujie Bai, Jiayong Liu, Yan Sun, Weihu Wang, Shaowen Xiao
BACKGROUND: Adult head and neck rhabdomyosarcoma (HNRMS) is an exceptionally rare malignancy, and there is a paucity of data and research dedicated to understanding its characteristics and management in adult populations. This study aimed to assess the outcomes and identify survival predictors in adult HNRMS. METHODS: We retrospectively evaluated 42 adult patients (> 16 years) with HNRMS who received radiotherapy (RT)-based treatment at our institute between 2008 and 2022...
March 14, 2024: BMC Cancer
https://read.qxmd.com/read/38473359/frontline-and-relapsed-rhabdomyosarcoma-far-rms-clinical-trial-a-report-from-the-european-paediatric-soft-tissue-sarcoma-study-group-epssg
#17
JOURNAL ARTICLE
Julia Chisholm, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen Rees, Gianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A Tweddle, Johannes H M Merks, Meriel Jenney
The Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) clinical trial is an overarching, multinational study for children and adults with rhabdomyosarcoma (RMS). The trial, developed by the European Soft Tissue Sarcoma Study Group (EpSSG), incorporates multiple different research questions within a multistage design with a focus on (i) novel regimens for poor prognostic subgroups, (ii) optimal duration of maintenance chemotherapy, and (iii) optimal use of radiotherapy for local control and widespread metastatic disease...
February 29, 2024: Cancers
https://read.qxmd.com/read/38455863/management-of-a-pure-uterine-corpus-rhabdomyosarcoma-in-a-postmenopausal-patient-a-rare-case-report-and-review-of-the-literature
#18
John Lugata, Caleigh Smith, Onesmo Mrosso, Doris Rwenyagila, Baraka Shao, Alex Mremi
KEY CLINICAL MESSAGE: Rhabdomyosarcoma of the female genital tract often involves the vagina and cervix. It usually occurs in infants and children. Such tumors are uncommon in the uterus, especially in adults. Treatment options are based on studies of younger individuals. ABSTRACT: Rhabdomyosarcoma (RMS) is a malignant mesenchymal neoplasm with a tendency to differentiate into skeletal muscle cells. RMS is an aggressive tumor that tends to develop in children and younger patients...
March 2024: Clinical Case Reports
https://read.qxmd.com/read/38454866/clinicodemographic-profile-of-orbital-exenteration-in-a-tertiary-eye-care-center-a-20-year-experience
#19
JOURNAL ARTICLE
Rachna Meel, Neelam Pushker, Shweta Das Chaurasia, Aishwarya Rathod, Mandeep Singh Bajaj, Seema Sen, Sahil Agrawal
PURPOSE: This study aimed to determine the clinical indications for orbital exenteration, demographic profile of these patients, and clinicopathologic correlations in the current times and to compare these results with previous published data. METHODS: It was a retrospective study. All exenterations performed at a tertiary eye care center over a period of 20 years (from January 2001 to June 2020) were retrospectively evaluated. Patient records were reviewed to obtain demographic data, presenting symptoms and their duration, laterality, and clinical and histopathologic diagnosis...
March 8, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38450697/small-bowel-metastasis-from-embryonal-rhabdomyosarcoma-of-the-extremity-a-case-report
#20
JOURNAL ARTICLE
P Joubert, M Mihalik
Rhabdomyosarcoma is the most common soft tissue tumour in children and adolescents, but extremely rare in adults with comparatively worse outcomes. Metastatic disease is not uncommon, but intra-abdominal metastases are exceedingly rare. We report an unusual case of ileal metastases from an upper extremity rhabdomyosarcoma in a 17-year-old male who presented with abdominal pain during a routine follow-up visit. Laparotomy and ileocecectomy for a perforated ileal mass confirmed metastatic embryonal rhabdomyosarcoma with 1 out of 14 positive lymph node metastases...
November 2023: South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie
keyword
keyword
96734
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.